|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007778,
umls-concept:C0008838,
umls-concept:C0015967,
umls-concept:C0022100,
umls-concept:C0025500,
umls-concept:C0152463,
umls-concept:C0205390,
umls-concept:C0456904,
umls-concept:C1298613,
umls-concept:C2603343,
umls-concept:C2678502
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-3-31
|
|
pubmed:abstractText |
To evaluate morbidity, mortality, maximum-tolerated dose (MTD), and outcome of intraoperative intracavitary hyperthermic cisplatin lavage in patients undergoing pleurectomy for malignant pleural mesothelioma (MPM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BuenoRaphaelR,
pubmed-author:CapalboLeahL,
pubmed-author:ChirieacLucian RLR,
pubmed-author:DekkersRene JRJ,
pubmed-author:HartiganPhillip MPM,
pubmed-author:JännePasi APA,
pubmed-author:JaklitschMichael TMT,
pubmed-author:RichardsWilliam GWG,
pubmed-author:SugarbakerDavid JDJ,
pubmed-author:YeapBeow YBY,
pubmed-author:ZellosLambrosL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1561-7
|
|
pubmed:meshHeading |
pubmed-meshheading:16575008-Aged,
pubmed-meshheading:16575008-Aged, 80 and over,
pubmed-meshheading:16575008-Cisplatin,
pubmed-meshheading:16575008-Combined Modality Therapy,
pubmed-meshheading:16575008-Female,
pubmed-meshheading:16575008-Humans,
pubmed-meshheading:16575008-Hyperthermia, Induced,
pubmed-meshheading:16575008-Male,
pubmed-meshheading:16575008-Maximum Tolerated Dose,
pubmed-meshheading:16575008-Mesothelioma,
pubmed-meshheading:16575008-Middle Aged,
pubmed-meshheading:16575008-Pleura,
pubmed-meshheading:16575008-Pleural Neoplasms,
pubmed-meshheading:16575008-Prospective Studies,
pubmed-meshheading:16575008-Treatment Failure
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
|
|
pubmed:affiliation |
Brigham and Women's Hospital, Boston, MA 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
